State-dependent opioid control of pain

Nature Reviews Neuroscience

Volumn 5, Issue 7, 2004, Pages 565-575

  Fields, Howard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; DIAMORPHINE; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALOXONE; NALTREXONE; OPIATE; PLACEBO;

ANALGESIA; DRUG EFFECT; HUMAN; MOTIVATION; MUSCLE SPINDLE AFFERENT NERVE; NERVE CELL; NEUROBIOLOGY; NOCICEPTION; NONHUMAN; PAIN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; REVIEW; REWARD; SEROTONINERGIC SYSTEM; STIMULUS RESPONSE;

EID: 3042789578     PISSN: 1471003X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrn1431     Document Type: Review

References (135)

1. Melzack, R. & Wall, P. D. Acute pain in an emergency clinic: latency of onset and descriptor patterns related to different injuries. Pain 14, 33-43 (1982).
2. Akil, H. et al. Endogenous opioids: overview and current issues. Drug Alcohol Depend. 51, 127-140 (1998).
3. Kieffer, B. L. & Gaveriaux-Ruff, C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66, 285-306 (2002).
4. Fields, H. L., Heinricher, M. M. & Mason, P. Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 14, 219-245 (1991).
5. Yaksh, T. L. & Rudy, T. A. Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain 4, 299-359 (1978). This is a thorough review of the initial mapping studies of CNS sites that are sensitive to the analgesic effect of opioids.
6. Heinricher, M. M. & McGaraughty, S. in State-Dependent Processing in Somatosensory Pathways (ed. Soja, P. J.) 487-503 (CRC Press, San Diego, 1998).
7. Fields, H. L. & Basbaum, A. I. in Textbook of Pain (eds Wall, P. D. & Melzack, R.) 309-329 (Churchill Livingstone, Edinburgh, 1999).
8. Neubert, M. J., Kincaid, W. & Heinricher, M. M. Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain (in the press). By selectively activating on cells, the authors provide definitive evidence that these cells facilitate nociceptive transmission.
9. Ackley, M. A., Hurley, R. W., Vimich, D. E. & Hammond, D. L. A cellular mechanism for the antinociceptive effect of a κ-opioid receptor agonist. Pain 91, 377-388 (2001). The authors demonstrate presynaptic control of glutamatergic inputs by KOR agonists in vitro.
10. Chieng, B. & Christie, M. J. Hyperpolarization by opioids acting on μ-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Br. J. Pharmacol. 113, 121-128 (1994).
11. Pan, Z. Z., Tershner, S. A. & Fields, H. L. Cellular mechanism for anti-analgesic action of agonists of the κ-opioid receptor. Nature 389, 382-385 (1997).
12. Julius, D. & Basbaum, A. I. Molecular mechanisms of nociception. Nature 413, 203-210 (2001).
13. Price, D. D. Psychological Mechanisms of Pain and Analgesia (IASP Press, Seattle, 1999). A classic book in which the author presents a thorough review of the psychophysics of pain, and of the cognitive and experimental modifiers of pain. He puts this perceptual evidence into a neurobiological and clinical perspective.
14. Willis, W. D. & Coggeshall, R. E. Sensory Mechanisms of the Spinal Cord (Plenum, New York, 1991).
15. Wall, P. D. & Melzack, R. (eds) Textbook of Pain (Churchill Livingstone, Edinburgh, 1999).
16. Casey, K. L. & Bushnell, M. C. (eds) Pain Imaging (IASP Press, Seattle, 2000).
17. Wall, P. D. The laminar organisation of dorsal horn and effects of descending impulses. J. Physiol. (Lond.) 188, 403-423 (1967). This is a seminal description of dorsal horn neurons as feature detectors with response properties that are subject to top-down modulation. Wall demonstrated that each dorsal horn lamina contained neurons with distinct physiological properties, and he placed the main focus of pain research on the spinal cord.
18. Reynolds, D. V. Surgery in the rat during electrical analgesia by focal brain stimulation. Science 164, 444-445 (1969). The original description of stimulation-produced analgesia in rodents.
19. Mayer, D. J., Wolfe, T. L., Akil, H., Carder, B. & Liebeskind, J. C. Analgesia from electrical stimulation in the brain stem of the rat. Science 174, 1351-1354 (1971).
20. Mayer, D. J. & Liebeskind, J. C. Pain reduction by focal stimulation of the brain: an anatomical and behavioural analysis. Brain Res. 68, 73-93 (1974).
21. Hosobuchi, Y., Adams, J. E. & Linchitz, R. Pain relief by electrical stimulation of the central gray matter in humans in its reversal by naloxone. Science 197, 183-186 (1977).
22. Baskin, D. S. et al. Autopsy analysis of the safety, efficacy and cartography of electrical stimulation of the central gray in humans. Brain Res. 371, 231-236 (1986).
23. Holden, J. E., van Poppel, A. Y. & Thomas, S. Antinociception from lateral hypothalamic stimulation may be mediated by NK1 receptors in the A7 catecholamine cell group in rat. Brain Res. 953, 195-204 (2002).
24. Liebeskind, J. C., Guilbaud, G., Besson, J. M. & Oliveras, J. L. Analgesia from electrical stimulation of the periaqueductal gray matter in the cat: behavioral observations and inhibitory effects on spinal cord interneurons. Brain Res. 50, 441-446 (1973).
25. Stein, C., Schafer, M. & Machelska, H. Attacking pain at its source: new perspectives on opioids. Nature Med. 9, 1003-1008 (2003).
26. Grudt, T. J. & Williams, J. μ-opioid agonists inhibit spinal trigeminal substantia gelatinosa neurons in guinea pig and rat. J. Neurosci. 14, 1646-1654 (1994).
27. 2, and μ-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord. J. Neurosci. 14, 4965-4971 (1994). This study demonstrates both pre- and postsynaptic actions of opioids at the first relay from primary afferent nociceptors to second-order dorsal horn neurons.
28. Mansour, A., Khachaturian, H., Lewis, M. E., Akil, H. & Watson, S. J. Anatomy of CNS opioid receptors. Trends Neurosci. 11, 308-314 (1988).
29. Mansour, A., Fox, C. A. & Watson, S. J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 22-29 (1995). A concise survey of MOR, KOR and DOR distribution in the CNS.
30. Arvidsson, U. et al. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15, 3328-3341 (1995).
31. Manning, B. H., Morgan, M. J. & Franklin, K. B. J. Morphine analgesia in the formalin test: evidence for forebrain and midbrain sites of action. Neuroscience 63, 289-294 (1994).
32. Burkey, A. R., Carstens, E., Wenniger, J. J., Tang, J. & Jasmin, L. An opioidergic cortical antinociception triggering site in the agranular insular cortex of the rat that contributes to morphine antinociception. J. Neurosci. 16, 6612-6623 (1996).
33. Tershner, S. A. & Helmstetter, F. J. Antinociception produced by μ-opiod receptor activation in the amygdala is partly dependent on activation of μ-opioid and neurotensin receptors in the ventral periaqueductal gray. Brain Res. 865, 17-26 (2000).
34. Kiefel, J. M., Rossi, G. C. & Bodnar, R. J. Medullary μ and δ opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res. 624, 151-161 (1993).
35. Roychowdhury, S. M. & Fields, H. L. Endogenous opioids acting at a medullary μ-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray. Neuroscience 74, 863-872 (1996).
36. Al-Rodhan, N., Chipkin, R. & Yaksh, T. L. The antinociceptive effects of SCH-32615, a neutral endopeptidase (enkephalinase) inhibitor, microinjected into the periaqueductal, ventral medulla and amygdala. Brain Res. 520, 123-130 (1990).
37. Watkins, L. R. & Mayer, D. J. Organization of endogenous opiate and nonopiate pain control systems. Science 216, 1185-1192 (1982).
38. Watkins, L. R., Young, E. G., Kinscheck, I. B. & Mayer, J. D. The neural basis of footshock analgesia: the role of specific ventral medullary nuclei. Brain Res. 276, 305-315 (1983).
39. Levine, J. D., Gordon, N. C., Jones, R. T. & Fields, H. L. The narcotic antagonist naloxone enhances clinical pain. Nature 272, 826-827 (1978). The first direct evidence that endogenous opioids modulate pain in humans. The authors used dental postoperative pain as the measure of action of the opioid-mediated analgesia system.
40. Pollo, A. et al. Response expectancies in placebo analgesia and their clinical relevance. Pain 93, 77-84 (2001).
41. Fields, H. L. Is there a facilitating component to central pain modulation? APS J. 1, 139-141 (1992).
42. Porreca, F., Ossipov, M. H. & Gebhart, G. F. Chronic pain and medullary descending facilitation. Trends Neurosci. 25, 319-325(2002).
43. Urban, M. O. & Gebhart, G. F. Supraspinal contributions to hyperalgesia. Proc. Natl Acad. Sci. USA 96, 7687-7692 (1999).
44. Zhuo, M. & Gebhart, G. F. Characterization of descending inhibition and facilitation from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Pain 42, 337-350 (1990).
45. Zhuo, M. & Gebhart, G. F. Characterization of descending facilitation and inhibition of spinal nociceptive transmission from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. J. Neurophys. 67, 1599-1614 (1992).
46. Urban, M. O., Coutinho, S. V. & Gebhart, G. F. Biphasic modulation of visceral nociception by neurotensin in rat rostral ventromedial medulla. J. Pharmacol. Exp. Ther. 290, 207-213 (1999).
47. Watkins, L. R. et al. Neurocircuitry of illness-induced hyperalgesia. Brain Res. 639, 283-299 (1994).
48. Morgan, M. M., Heinricher, M. M. & Fields, H. L. Inhibition and facilitation of different nocifensor reflexes by spatially remote noxious thermal stimuli. J. Neurophysiol. 72, 1152-1160 (1994).
49. Haws, C. M., Williamson, A. M. & Fields, H. L. Putative nociceptive modulatory neurons in the dorsolateral pontomesencephalic reticular formation. Brain Res. 483, 272-282 (1989).
50. Heinricher, M. M., Cheng, Z. F. & Fields, H. L. Evidence for two classes of nociceptive modulating neurons in the periaqueductal gray. J. Neurosci. 7, 271-278 (1987).
51. Fields, H. L., Malick, A. & Burstein, R. Dorsal horn projection targets of on and off cells in the rostral ventromedial medulla. J. Neurophysiol. 74, 1742-1759 (1995). Microstimulation is used to track the terminals of on and off cells into dorsal horn laminae I, II and V.
52. Heinricher, M. M., McGaraughty, S. & Farr, D. A. The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine. Pain 81, 57-65 (1999).
53. Heinricher, M. M., McGaraughty, S. & Grandy, D. K. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J. Neurophysiol. 78, 3351-3358 (1997).
54. Heinricher, M. M., McGaraughty, S. & Tortorici, V. Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. J. Neurophysiol. 85, 280-286 (2001).
55. Morgan, M. M. & Fields, H. L. Pronounced changes in the activity of nociceptive modulatory neurons in the rostral ventromedial medulla in response to prolonged thermal noxious stimuli. J. Neurophysiol. 72, 1161-1170 (1994).
56. Porreca, F. et al. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expression the μ-opioid receptor. J. Neurosci. 21, 5281-5288 (2001).
57. Gardell, L. R. et al. Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation. J. Neurosci. 23, 8370-8379 (2003).
58. Barbaro, N. M., Heinricher, M. M. & Fields, H. L. Putative nociceptive modulatory neurons in the rostral ventromedial medulla of the rat display highly correlated firing patterns. Somatosens. Motor Res. 6, 413-425 (1989).
59. Heinricher, M. M., Barbaro, N. M. & Fields, H. L. Putative nociceptive modulating neurons in the rostral ventromedial medulla of the rat: firing of on- and off-cells is related to nociceptive responsiveness. Somatosens. Motor Res. 6, 427-439 (1989).
60. Heinricher, M. M. & McGaraughty, S. Analysis of excitatory amino acid transmission within the rostral ventromedial medulla: implications for circuitry. Pain 75, 247-255 (1998).
61. Mason, P. Contributions of the medullary raphe and ventromedial reticular region to pain modulation and other homeostatic functions. Annu. Rev. Neurosci. 24, 737-777 (2001).
62. Leung, C. G. & Mason, P. Physiological properties of raphe magnus neurons during sleep and waking. J. Neurophysiol. 81, 584-595 (1999). This study uses single unit recording in awake rats to demonstrate state dependence of firing patterns in on, off and neutral cells in the rostral ventromedial medulla.
63. Akil, H., Meng, F., Devine, D. P. & Watson, S. J. Molecular and neuroanatomical properties of the endogenous opiod system: implications for treatment of opiate addiction. Semin. Neurosci. 9, 70-83 (1997).
64. Eguchi, M. Recent advances in selective opioid receptor agonists and antagonists. Med. Res. Rev. 24, 182-212 (2004).
65. 14] nociceptin/orphanin FQ binding sites in macaque primate CNS. Neuroscience 118, 513-523 (2003).
66. Pan, Z. Z., Williams, J. T. & Osborne, P. B. Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro. J. Physiol. (Lond.) 427, 519-532 (1990). The first in vitro study of RVM neurons. The authors use sharp electrodes and demonstrate distinct populations of neurons that are either directly inhibited or disinhibited by opioid agonists.
67. Heinricher, M. M., Morgan, M. M. & Fields, H. L. Direct and indirect action of morphine on medullary neurons that modulate nociception. Neuroscience 48, 533-543 (1992).
68. Vaughan, C. W. & Christie, M. J. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J. Physiol. (Lond.) 498, 463-472 (1997).
69. Vaughan, C. W. et al. Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br. J. Pharmacol. 139, 362-367 (2003).
70. Heinricher, M. M., Morgan, M. M., Tortorici, V. & Fields, H. L. Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla. Neuroscience 63, 279-288 (1994).
71. Heinricher, M. M. & Tortorici, V. Interference with GABA transmission in the rostral ventromedial medulla: disinhibition of off-cells as a central mechanism in nociceptive modulation. Neuroscience 63, 533-546 (1994).
72. Finnegan, T. F., Li, D. P., Chen, S. R. & Pan, H. L. Activation of μ-opioid receptors inhibits synaptic inputs to spinally projecting rostral ventromedial medulla neurons. J. Pharmacol. Exp. Ther. 309, 476-483 (2004).
73. Connor, M., Schuller, A., Pintar, J. E. & Christie, M. J. μ-Opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br. J. Pharmacol. 126, 1553-1558 (1999).
74. Heinricher, M. M. & Fields, H. L. in The Delta Receptor: Molecular and Effect of Delta Opioid Compounds (ed. Woods, J.) 467-480 (Marcel Dekker, New York, 2003).
75. Rossi, G. C., Pasternak, G. W. & Bodnar, R. J. μ- and δ-opioid synergy between the periaqueductal gray and the rostro-ventral medulla. Brain Research 665, 85-93 (1994).
76. Ossipov, M. H., Kovelowski, C. J., Nichols, M. L., Hruby, V. J. & Porreca, F. Characterization of supraspinal antinociceptive actions of opioid δ agonists in the rat. Pain 62, 287-293 (1995).
77. 2+ channel currents of acutely dissociated rat periaqueductal grey neurons. J. Physiol. (Lond.) 509, 47-58 (1998).
78. Kiefel, J. M., Rossi, G. C. & Bodnar, R. J. Medullary μ- and δ-opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res. 624, 151-161 (1993).
79. Hirakawa, N., Tershner, S. A. & Fields, H. L. Highly δ-selective antagonists in the RVM attenuate the antinociceptive effect of PAG DAMGO. Neuroreport 10, 3125-3129 (1999).
80. Thorat, S. N. & Hammond, D. L. Modulation of nociception by microinjection of δ-1 and δ-2 opioid receptor ligands in the ventromedial medulla of the rat. J. Pharmacol. Exp. Ther. 283, 1185-1192 (1997).
81. Harasawa, I., Fields, H. L. & Meng, I. D. δ-opioid receptor mediated actions in the rostral ventromedial medulla on tail flick latency and nociceptive modulatory neurons. Pain 85, 255-262 (2000).
82. Cahill, C. M., Morinville, A., Hoffert, C., O'Donnell, D. & Beaudet, A. Up-regulation and trafficking of δ-opioid receptor in a model of chronic inflammation: implications for pain control. Pain 101, 199-208 (2003).
83. Hurley, R. W. & Hammond, D. L. The analgesic effects of supraspinal μ and δ opioid receptor agonists are potentiated during persistent inflammation. J. Neurosci. 20, 1249-1259 (2000).
84. Vaughan, C. W., Ingram, S. L. & Christie, M. J. Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J. Neurosci 17, 996-1003 (1997). References 84-88 demonstrate the robust and promiscuous inhibition that is produced by orphanin in both PAG and RVM.
85. Pan, Z., Hirakawa, N. & Fields, H. L. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron 26, 515-522 (2000).
86. Vaughan, C. W. et al. Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro. J. Physiol. (Lond.) 534, 849-859 (2001).
87. Darland, T., Heinricher, M. M. & Grandy, D. K. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci. 21, 215-221 (1998).
88. Millan, M. J. κ-opioid receptor-mediated antinociception in the rat. I. Comparative actions of μ- and κ-opioids against noxious, thermal, pressure and electrical stimuli. J. Pharmacol. Exp. Ther. 251, 334-341 (1989).
89. Millan, M. J., Czlonkowski, A., Lipkowski, A. & Herz, A. κ-opioid receptor-mediated antinocicepton in the rat. II. Supraspinal in addition to spinal sites of action. J. Pharmacol. Exp. Ther. 251, 342-350 (1989).
90. Pan, Z. Z. μ-Opposing actions of the κ-opioid receptor. Trends Pharmacol. Sci. 19, 94-98 (1998).
91. Bederson, J. B., Fields, H. L. & Barbaro, N. M. Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased ON-cell activity in the rostral ventromedial medulla. Somatosens. Motor Res. 7, 185-203 (1990).
92. Kaplan, H. & Fields, H. L. Hyperalgesia acute opioid abstinence: evidence for a nociceptive facilitating function of the rostral ventromedial medulla. J. Neurosci. 11, 1433-1439 (1991).
93. Bandler, R. & Keay, K. A. in Progress in Brain Research Vol. 107 (eds Holstege, G., Bandler, R. & Saper, C.) 285-300 (Elsevier, Amsterdam, 1996).
94. Fanselow, M. S. Conditioned fear-induced opiate analgesia: a competing motivational state theory of stress analgesia. Ann. NY Acad. Sci. 467, 40-54 (1986).
95. Bolles, R. C. & Fanselow, M. S. A perceptual-defensive-recuperative model of fear and pain. Behav. Brain Sci. 3, 291-323 (1980).
96. Johansen, J. P., Fields. H. L. Manning. B. H. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc. Natl Acad. Sci. USA 98, 8077-8082 (2001).
97. Johansen, J. P. & Fields, H. L. Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal. Nature Neurosci. (in the press).
98. Kavaliers, M. & Colwell, D. D. Sex differences in opioid and non-opioid mediated predator-induced analgesia in mice. Brain Res. 568, 173-177 (1991).
99. Miczek, K. A. & Winslow, J. T. Analgesia and decrement in operant performance in socially defeated mice: selective cross-tolerance to morphine and antagonism by naltrexone. Psychopharmacology (Berl.) 92, 444-451 (1987).
100. Bellgowan, P. S. F. & Heimstetter, F. J. The role of μ and κ-opioid receptors within the periaqueductal gray in the expression of conditional hypoalgesia. Brain Res. 791, 83-89 (1998).
101. Helmstetter, F. J., Bellgowan, P. S. & Poore, L. H. Microinfusion of μ- but not δ- or κ-opioid agonists into the basolateral amygdala results in inhibition of the tail flick reflex in pentobarbital-anesthetized rats. J. Pharmacol. Exp. Ther. 275, 381-388 (1995).
102. Foo, H. & Helmstetter, F. J. Hypoalgesia elicited by a conditioned stimulus is blocked by a μ-, but not a δ- or a κ-opioid antagonist injected into the rostral ventromedial medulla. Pain 83, 427-431 (1999).
103. Foo, H. & Helmstetter, F. J. Activation of κ-opioid receptors in the rostral ventromedial medulla blocks stress-induced antinociception. Neuroreport 11, 3349-3352 (2000).
104. Segato, F. N., Castro-Souza, C., Segato, E. N., Morato, S. & Coimbra, N. C. Sucrose ingestion causes opioid analgesia. Braz. J. Med. Biol. Res. 30, 981-984 (1997).
105. Blass, E., Fitzgerald, E. & Kehoe, P. Interactions between sucrose, pain and isolation distress. Pharmacol. Biochem. Behav. 26, 483-489 (1987).
106. Bucher, H. U. et al. Sucrose reduces pain reaction to heel lancing in preterm infants: a placebo-controlled, randomized and masked study. Pediatr. Res. 38, 332-335 (1995).
107. Dutta, R., Mukherjee, K. & Mathur, R. Effect of VMH lesion on sucrose-fed analgesia in formalin pain. Jpn J. Physiol. 51, 63-69 (2001).
108. Dum, J. & Herz, A. Endorphinergic modulation of neural reward systems indicated by behavioral changes. Pharmacol. Biochem. Behav. 21, 259-266 (1984). The authors show that rats conditioned to expect sucrose when they are placed on a hot plate will show elevated escape thresholds. This analgesic effect is blocked by the opioid antagonist naloxone.
109. Schmidt, B. L., Tambeli, C. H., Levine, J. D. & Gear, R. W. μ/δ Cooperativity and opposing κ-opioid effects in nucleus accumbens-mediated antinociception in the rat. Eur. J. Neurosci. 15, 861-868 (2002).
110. Kelley, A. E. et al. Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav. 76, 365-377 (2002).
111. Levine, J. D., Gordon, N. C. & Fields, H. L. The mechanism of placebo analgesia. Lancet 2, 654-657 (1978). Using the model of dental postoperative pain, this is the first evidence for its placebo mediation by endogenous opioids.
112. Benedetti, F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 64, 535-543 (1996).
113. Grevert, P. & Goldstein, A. in Placebo: Theory, Research and Mechanisms (eds White, L., Tursky, B. & Shwartz, G. E.) 332-350 (The Guilford Press, New York, 1985).
114. Price, D. D. et al. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 83, 147-156 (1999).
115. Montgomery, G. H. & Kirsch, I. Classical conditioning and the placebo effect. Pain 72, 107-113 (1997).
116. Amanzio, M. & Benedetti, F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J. Neurosci. 19, 484-494 (1999).
117. Voudouris, N. J., Peck, C. L. & Coleman, G. The role of conditioning and verbal expectancy in the placebo response. Pain 43, 121-128 (1990).
118. de la Fuente-Fernandez, R., Schulzer, M. & Stoessl, A. J. The placebo effect in neurological disorders. Lancet Neurol. 1, 85-91 (2002).
119. Petrovic, P., Kalso, E., Petersson, K. M. & Ingvar, M. Placebo and opioid analgesia - imaging a shared neuronal network. Science 295, 1737-1740 (2002). Using positron emission tomography, the authors show extensive overlap between brain areas that are activated by the short-acting MOR agonist remifentanyl and a placebo manipulation that produces analgesia.
120. Wager, T. D. et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303, 1162-1167 (2004).
121. An, X., Bandler, R., Ongur, D. & Price. J. L. Prefrontal cortical projections to longitudinal columns in the midbrain periaqueductal gray in macaque monkeys. J. Comp. Neurol. 401, 455-479 (1998).
122. Kirsch, P. et al. Anticipation of reward in a nonaversive differential conditioning paradigm and the brain reward system: an event-related fMRI study. Neuroimaqe 20, 1086-1095 (2003).
123. Shidara, M. & Richmond, B. J. Anterior cingulate: single neuronal signals related to degree of reward expectancy. Science 296, 1709-1711 (2002).
124. Kunishio, K. & Haber, S. N. Primate cingulostriatal projection: limbic striatal versus sensorimotor striatal input. J. Comp. Neurol. 350, 337-356 (1994).
125. Becerra, L., Breiter, H. C., Wise, R., Gonzalez, R. G. & Borsook, D. Reward circuitry activation by noxious thermal stimuli. Neuron 32, 927-946 (2001).
126. Suzuki, R., Morcuende, S., Webber, M., Hunt, S. P. & Dickenson, A. H. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nature Neurosci. 5, 1319-1326 (2002).
127. Le Bars, D. in Serotonin and Pain (eds Osbome, N. M. & Hamon, M.) 171-226 (John Wiley, New York, 1988).
128. Potrebic, S. B., Fields, H. L. & Mason, P. Serotonin immunoreactivity is contained in one physiological cell class in the rat rostral ventromedial medulla. J. Neurosci. 14, 1655-1665 (1994). Using in vivo intracellular recording, on, off and neutral cells were identified physiologically and filled with biocytin for later immunocytochemistry. Serotonin was only found in neutral cells.
129. Marinelli, S., Vaughan, C. W., Schnell, S. A., Wessendorf, M. W. & Christie, M. J. Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. J. Neurosci. 22, 10847-10855 (2002). The authors use a marker injected into the spinal cord and transported retrogradely to identify spinally projecting RVM neurons. They show that a significant number of spinally-projecting serotonergic neurons express functional μ- and κ-opioid receptors.
130. Mason, P. & Gao, K. Raphe magnus serotonergic neurons tonically modulate nociceptive transmission. Pain Forum 7, 143-150 (1998).
131. Huang, L.-Y. M. Tonic release of serotonin. Pain Forum 7, 151-154 (1998).
132. Yaksh, T. L. & Wilson, P. R. Spinal serotonin system mediates antinociception. J. Pharmacol. Exp. Ther. 208, 446-453 (1979).
133. Zhuo, M. & Gebhart, G. F. Spinal serotonin receptors mediate descending facilitation of a nociceptive reflex from the nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. Brain Res. 550, 35-48 (1991).
134. Calejesan, A. A., Chang, M. H. & Zhuo, M. Spinal serotonergic receptors meidate facilitation of a nociceptive reflex by subcutaneous formalin inejction into the hindpaw in rats. Brain Res. 798, 46-54 (1998).
135. 3 receptors in the anaesthetized rat. Pain 89, 81-88 (2000).